Apeloa PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Apeloa PharmaceuticalLtd has a total shareholder equity of CN¥6.6B and total debt of CN¥939.9M, which brings its debt-to-equity ratio to 14.3%. Its total assets and total liabilities are CN¥13.3B and CN¥6.8B respectively. Apeloa PharmaceuticalLtd's EBIT is CN¥1.1B making its interest coverage ratio -16.5. It has cash and short-term investments of CN¥3.9B.
Key information
14.3%
Debt to equity ratio
CN¥939.86m
Debt
| Interest coverage ratio | -16.5x |
| Cash | CN¥3.89b |
| Equity | CN¥6.59b |
| Total liabilities | CN¥6.75b |
| Total assets | CN¥13.34b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 000739's short term assets (CN¥8.8B) exceed its short term liabilities (CN¥6.5B).
Long Term Liabilities: 000739's short term assets (CN¥8.8B) exceed its long term liabilities (CN¥274.9M).
Debt to Equity History and Analysis
Debt Level: 000739 has more cash than its total debt.
Reducing Debt: 000739's debt to equity ratio has increased from 2.7% to 14.3% over the past 5 years.
Debt Coverage: 000739's debt is well covered by operating cash flow (143.5%).
Interest Coverage: 000739 earns more interest than it pays, so coverage of interest payments is not a concern.